The global market for insulin pumps was
valued at around USD 2.3 billion in 2015 and is expected to reach USD
4.3 billion by 2022, growing at a CAGR of around 9.5% during the
forecast period of 2016 to 2022. Insulin pumps are portable devices
attached to the body that continuously deliver amounts of rapid or short
acting insulin through a catheter placed under the skin. These are better
alternative to insulin injections as they reduce the need for multiple
insulin injections per day and give the user increased ability to
control blood glucose levels. Approximately 1 in 1,000 people with
diabetes wears an insulin pump. An insulin pump consists of the main
pump unit which holds an insulin reservoir which typically holds between
176 and 300 units of insulin. The reservoir is attached to a long, thin
piece of tubing with a needle or cannula at one end. The tubing and the
bit at the end are called the infusion set. Insulin pump therapy is
also referred to as continuous subcutaneous insulin infusion therapy.
Diabetes disease is growing across the
globe at an extraordinary pace and has become a serious health issue
during the last two decades. It is a major cause of mortality in the age
group of 20–79 years. Based on its rapidly increasing incidence, it has
been declared a global epidemic by the World Health Organization (WHO).
According to the International Diabetes Federation (IDF), the number of
diabetic patients reached 415 million in 2015 globally and is expected
to reach around 642 million by 2040. According to the IDF, global
healthcare expenditures to treat diabetes and its complications was USD
673 billion in 2015, representing 12% of total global healthcare
expenditures and is expected to exceed USD 802 billion by 2040.
Rise in base of geriatric population,
increasing incidence rates of diabetes worldwide, benefits of insulin
pumps over injections such as improved glucose control, convenience, and
flexibility; growing awareness among the population, and increasing
preference for non-invasive methods are expected to drive the market at a
significant growth rate in the coming years. However, skin infection,
weight gain and high costs associated with these devices are some of the
restraining factors which could hinder the market.
Geographically, North America is the
leading contributor to the market and is expected to retain its position
during the forecast period due to the presence of large number of
geriatric population and large base of population with high purchasing
power. However, Asia-Pacific market is expected to grow at a faster rate
during the forecast period. This is predominantly due to increased
healthcare awareness, improved economic growth, increasing number of
obesity cases and growing awareness among the population.
- Animas Corp
- Insulet Corp.
- Medtronic Diabetes
- Roche Insulin Delivery Systems
- SOOIL Development Co. Ltd.
- Tandem Diabetes Care, Inc.
The report delivers a strategic analysis
of the global market for insulin pumps and growth forecast for the
period from 2016 – 2022. The scope of the report includes competitive
analysis of various market players who are operating in the market,
segmental analysis based on type of component. It also covers
geographical analysis of the market with growth forecast for the period
of 2016 – 2022. The Porter’s Five Forces analysis and value chain
analysis included in the report provides an insight into market dynamics
and industry competition.
Moreover, the report also includes
growth strategies and entry barriers to be considered to cater to the
exact business opportunities in this market. Additionally, to aid in
strategic decision making, the report also includes competitive
profiling of leading players, recent developments in the industry and
various business strategies adopted by them. This report will help
players in global insulin pumps market to plan and implement their
strategies in different market areas such as emerging geographies, and
1. Scope of the report
1.1 Report description
1.2 Research methodology
1.3 List of abbreviations
1.4 Market segmentation
2 Executive summary
3 Qualitative analysis
3.1 Market overview
3.2 Porters five forces analysis
3.3 Cost comparison of insulin pumps
3.4 Top insulin pumps comparison
3.5 Market share analysis of key players, 2015
3.6 Competitive matrix of the key companies
4 Global insulin pumps market, by component, 2015 – 2022
4.1 Insulin pumps
4.2 Consumables (reservoirs, batteries, infusion sets, skin dressings, adhesives, and antiseptic wipe)
5 Global insulin pump market, by geography, 2015 – 2022
5.1 North America
5.1.1 Insulin pumps
5.1.2 Consumables (reservoirs, batteries, infusion sets, skin dressings, adhesives, and antiseptic wipe)
5.2.1 Insulin pumps
5.2.2 Consumables (reservoirs, batteries, infusion sets, skin dressings, adhesives, and antiseptic wipe)
5.3.1 Insulin pumps
5.3.2 Consumables (reservoirs, batteries, infusion sets, skin dressings, adhesives, and antiseptic wipe)
5.4 Rest of the World
5.4.1 Insulin pumps
5.4.2 Consumables (reservoirs, batteries, infusion sets, skin dressings, adhesives, and antiseptic wipe)
6 Company profiles
6.1 Insulet Corp.
6.2 Medtronic Diabetes
6.3 Roche Insulin Delivery Systems
6.4 SOOIL Development Co. Ltd.
6.5 Tandem Diabetes Care, Inc.
6.7 Nipro Diagnostic, Inc.
6.8 Animas Corp